BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gaspar MM, Neves S, Portaels F, Pedrosa J, Silva MT, Cruz ME. Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection. Antimicrob Agents Chemother 2000;44:2424-30. [PMID: 10952590 DOI: 10.1128/AAC.44.9.2424-2430.2000] [Cited by in Crossref: 24] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Lopes RM, Corvo ML, Eleutério CV, Carvalheiro MC, Scoulica E, Cruz MEM. Formulation of oryzalin (ORZ) liposomes: In vitro studies and in vivo fate. European Journal of Pharmaceutics and Biopharmaceutics 2012;82:281-90. [DOI: 10.1016/j.ejpb.2012.06.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
2 Kerry RG, Gouda S, Sil B, Das G, Shin HS, Ghodake G, Patra JK. Cure of tuberculosis using nanotechnology: An overview. J Microbiol 2018;56:287-99. [PMID: 29721825 DOI: 10.1007/s12275-018-7414-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Ferreira M, Pinto SN, Aires-da-Silva F, Bettencourt A, Aguiar SI, Gaspar MM. Liposomes as a Nanoplatform to Improve the Delivery of Antibiotics into Staphylococcus aureus Biofilms. Pharmaceutics 2021;13:321. [PMID: 33801281 DOI: 10.3390/pharmaceutics13030321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Dogbe MG, Mafilaza AY, Eleutério CV, Cabral-Marques H, Simões S, Gaspar MM. Pharmaceutical Benefits of Fluticasone Propionate Association to Delivery Systems: In Vitro and In Vivo Evaluation. Pharmaceutics 2019;11:E521. [PMID: 31658657 DOI: 10.3390/pharmaceutics11100521] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
5 Krasnopol’skii YM, Balaban’yan VY, Shobolov DL, Shvets VI. Prospective clinical applications of nanosized drugs. Russ J Gen Chem 2013;83:2524-40. [DOI: 10.1134/s1070363213120517] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
6 Gkartziou F, Giormezis N, Spiliopoulou I, Antimisiaris SG. Nanobiosystems for Antimicrobial Drug-Resistant Infections. Nanomaterials (Basel) 2021;11:1075. [PMID: 33922004 DOI: 10.3390/nano11051075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]